ACHE and Alzheimer disease: Currently, there is no specific prevention or treatment for AD patients, and clinically applied acetylcholinesterase inhibitors and memantine can only slow down the progression of the disease (Koseoglu, 2019), while corresponding supportive treatment and symptomatic treatment can be taken for the complications of severe patients, which cannot achieve the expectation of preventing the development of the disease or promoting the recovery of the disease.